Mariena V. Mattson

934 total citations
39 papers, 769 citations indexed

About

Mariena V. Mattson is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Mariena V. Mattson has authored 39 papers receiving a total of 769 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 18 papers in Organic Chemistry and 18 papers in Cellular and Molecular Neuroscience. Recurrent topics in Mariena V. Mattson's work include Pharmacological Receptor Mechanisms and Effects (16 papers), Receptor Mechanisms and Signaling (12 papers) and Neuropeptides and Animal Physiology (9 papers). Mariena V. Mattson is often cited by papers focused on Pharmacological Receptor Mechanisms and Effects (16 papers), Receptor Mechanisms and Signaling (12 papers) and Neuropeptides and Animal Physiology (9 papers). Mariena V. Mattson collaborates with scholars based in United States, Belgium and Italy. Mariena V. Mattson's co-authors include Kenner C. Rice, Arthur E. Jacobson, Andrew Thurkauf, Arthur E. Jacobson, Richard A. Glennon, Michael Rafferty, Katherine Davis, Seoung‐Soo Hong, Brian Grella and Luca Costantino and has published in prestigious journals such as Proceedings of the National Academy of Sciences, FEBS Letters and Journal of Medicinal Chemistry.

In The Last Decade

Mariena V. Mattson

38 papers receiving 741 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mariena V. Mattson United States 16 477 355 246 87 57 39 769
Carol Smith United States 17 445 0.9× 321 0.9× 220 0.9× 118 1.4× 94 1.6× 20 796
J.M. Kamenka France 16 607 1.3× 692 1.9× 88 0.4× 88 1.0× 16 0.3× 38 1.0k
Mark R. Szewczak United States 10 267 0.6× 320 0.9× 135 0.5× 129 1.5× 47 0.8× 13 662
Dorota Matecka United States 13 398 0.8× 580 1.6× 83 0.3× 102 1.2× 38 0.7× 31 716
Maurice W. Gittos France 9 196 0.4× 168 0.5× 112 0.5× 59 0.7× 18 0.3× 21 445
Cody J. Wenthur United States 17 426 0.9× 356 1.0× 132 0.5× 119 1.4× 95 1.7× 43 987
Marshall B. Wallach United States 15 177 0.4× 269 0.8× 134 0.5× 176 2.0× 49 0.9× 27 697
Mark P. Wentland United States 22 640 1.3× 346 1.0× 486 2.0× 165 1.9× 11 0.2× 68 1.2k
M. Edward Pierson United States 16 306 0.6× 429 1.2× 74 0.3× 90 1.0× 23 0.4× 23 687
Klaus K. Weinhardt United States 13 249 0.5× 221 0.6× 293 1.2× 68 0.8× 25 0.4× 25 634

Countries citing papers authored by Mariena V. Mattson

Since Specialization
Citations

This map shows the geographic impact of Mariena V. Mattson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariena V. Mattson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariena V. Mattson more than expected).

Fields of papers citing papers by Mariena V. Mattson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mariena V. Mattson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariena V. Mattson. The network helps show where Mariena V. Mattson may publish in the future.

Co-authorship network of co-authors of Mariena V. Mattson

This figure shows the co-authorship network connecting the top 25 collaborators of Mariena V. Mattson. A scholar is included among the top collaborators of Mariena V. Mattson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariena V. Mattson. Mariena V. Mattson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Janetka, James W., M. Scott Furness, Xiaoyan Zhang, et al.. (2003). Enantioconvergent Synthesis of (−)-(2R,5S)-1-Allyl-2,5-dimethylpiperazine, an Intermediate to δ-Opioid Receptor Ligands. The Journal of Organic Chemistry. 68(10). 3976–3980. 8 indexed citations
2.
May, Everette L., Arthur E. Jacobson, Mariena V. Mattson, et al.. (1998). Synthesis, in vitro, and in vivo activity of N-p-substituted-benzyl- (- )- and (+)-N-normetazocines, (-)- and (+)-N-normorphinans, N- norketobemidones, and (-)-N-nor-4,5-epoxymorphinans. 8(6). 311–321. 9 indexed citations
3.
Bertha, Craig M., Bertold J. Vilner, Mariena V. Mattson, et al.. (1995). (E)-8-Benzylidene Derivatives of 2-Methyl-5-(3-hydroxyphenyl)morphans: Highly Selective Ligands for the .sigma.2 Receptor Subtype. Journal of Medicinal Chemistry. 38(24). 4776–4785. 10 indexed citations
4.
May, Everette L., Mario D. Aceto, Edward R. Bowman, et al.. (1994). Antipodal .alpha.-N-(Methyl through Decyl)-N-normetazocines (5,9.alpha.-Dimethyl-2'-hydroxy-6,7-benzomorphans): In vitro and In vivo Properties. Journal of Medicinal Chemistry. 37(20). 3408–3418. 39 indexed citations
5.
Bertha, Craig M., Mariena V. Mattson, JUDITH L. FLIPPEN‐ANDERSON, et al.. (1994). A Marked Change of Receptor Affinity of the 2-Methyl-5-(3-hydroxyphenyl)morphans upon Attachment of an (E)-8-Benzylidene Moiety: Synthesis and Evaluation of a New Class of .sigma. Receptor Ligands. Journal of Medicinal Chemistry. 37(19). 3163–3170. 18 indexed citations
6.
Raulli, Robert, B. Jackson, Narendra N. Tandon, et al.. (1994). Phencyclidine inhibits epinephrine-stimulated platelet aggregation independently of high affinity N-methyl-d-aspartate (NMDA)-type glutamatereceptors. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1224(2). 175–180. 6 indexed citations
7.
Calderon, Silvia N., Sari Izenwasser, J. Silvio Gutkind, et al.. (1994). Novel 1-Phenylcycloalkanecarboxylic Acid Derivatives Are Potent and Selective .sigma.1 Ligands. Journal of Medicinal Chemistry. 37(15). 2285–2291. 20 indexed citations
8.
Raymon, Lionel P., et al.. (1993). Synthesis and biological evaluation of 1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine homologs at dopamine-uptake and phencyclidine-, and .sigma.-binding sites. Journal of Medicinal Chemistry. 36(9). 1188–1193. 17 indexed citations
10.
Thurkauf, Andrew, Mariena V. Mattson, Scott J. Richardson, et al.. (1992). Analogs of the dioxolanes dexoxadrol and etoxadrol as potential phencyclidine-like agents. Synthesis and structure activity relationships. Journal of Medicinal Chemistry. 35(8). 1323–1329. 23 indexed citations
11.
Costa, Brian R. de, Mariena V. Mattson, Clifford George, & Joannes T. M. Linders. (1992). Synthesis, configuration, and activity of isomeric 2-phenyl-2-(N-piperidinyl)bicyclo[3.1.0]hexanes at phencyclidine and .sigma. binding sites. Journal of Medicinal Chemistry. 35(25). 4704–4712. 5 indexed citations
12.
Schweri, Margaret M., Andrew Thurkauf, Mariena V. Mattson, & K.C. Rice. (1992). Fourphit: a selective probe for the methylphenidate binding site on the dopamine transporter.. Journal of Pharmacology and Experimental Therapeutics. 261(3). 936–942. 11 indexed citations
13.
IORIO, M. A., Lamberto Tomassini, Mariena V. Mattson, Clifford George, & Arthur E. Jacobson. (1991). Synthesis, stereochemistry, and biological activity of the 1-(1-phenyl-2-methylcyclohexyl)piperidines and the 1-(1-phenyl-4-methylcyclohexyl)piperidines. Absolute configuration of the potent trans-(-)-1-(1-phenyl-2-methylcyclohexyl)piperidine. Journal of Medicinal Chemistry. 34(8). 2615–2623. 10 indexed citations
14.
Thurkauf, Andrew, Mariena V. Mattson, Charles P. France, et al.. (1990). Synthesis, phencyclidine-like pharmacology, and antiischemic potential of meta-substituted 1-(1-phenylcyclohexyl)-1,2,3,6-tetrahydropyridines. Journal of Medicinal Chemistry. 33(8). 2211–2215. 4 indexed citations
15.
Reid, Audrey A., Mariena V. Mattson, B. R. DE COSTA, et al.. (1990). Specificity of phencyclidine-like drugs and benzomorphan opiates for two high affinity phencyclidine binding sites in guinea pig brain. Neuropharmacology. 29(9). 811–817. 19 indexed citations
16.
Rothman, Richard B., Arthur E. Jacobson, Mariena V. Mattson, et al.. (1989). Probes for narcotic receptor mediated phenomena. 15. (3S,4S)-(+)-trans-3-Methylfentanyl isothiocyanate, a potent site-directed acylating agent for the .delta.-opioid receptors in vitro. Journal of Medicinal Chemistry. 32(6). 1392–1398. 20 indexed citations
17.
Thurkauf, Andrew, et al.. (1988). Synthesis, pharmacological action, and receptor binding affinity of the enantiomeric 1-(1-phenyl-3-methylcyclohexyl)piperidines. Journal of Medicinal Chemistry. 31(8). 1625–1628. 12 indexed citations
18.
Thurkauf, Andrew, Robert L. Balster, Everette L. May, et al.. (1988). Synthesis, absolute configuration, and molecular modeling study of etoxadrol, a potent phencyclidine-like agonist. Journal of Medicinal Chemistry. 31(12). 2257–2263. 15 indexed citations
19.
Jacobson, Arthur E., Mariena V. Mattson, Michael Rafferty, et al.. (1987). Enantiomeric and diastereomeric dioxadrols: behavioral, biochemical and chemical determination of the configuration necessary for phencyclidine-like properties.. Journal of Pharmacology and Experimental Therapeutics. 243(1). 110–117. 20 indexed citations
20.
Freedman, Robert, Barry J. Hoffer, Mariena V. Mattson, et al.. (1986). Antagonism of phencyclidine action by metaphit in rat cerebellar Purkinje neurons: an electrophysiological study.. Proceedings of the National Academy of Sciences. 83(8). 2724–2727. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026